Martin Hasselblatt Selected Research

Martin Hasselblatt Research Topics

Disease

57	Neoplasms (Cancer) 10/2023 - 10/2003
15	Rhabdoid Tumor (Rhabdoid Tumors) 01/2024 - 10/2006
14	Glioma (Gliomas) 01/2022 - 11/2008
9	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2006
9	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 05/2020 - 01/2006
9	Medulloblastoma 01/2020 - 07/2009
8	Typical Teratoid Rhabdoid Tumor 01/2022 - 06/2011
8	Choroid Plexus Papilloma 12/2021 - 01/2006
7	Primitive Neuroectodermal Tumors (PNET) 02/2016 - 11/2010
5	Carcinogenesis 01/2023 - 12/2012
5	Choroid Plexus Carcinoma 05/2020 - 01/2006
5	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 11/2008
4	Astrocytoma (Pilocytic Astrocytoma) 12/2018 - 08/2013
4	Ependymoma 01/2014 - 10/2003
4	Hypoxia (Hypoxemia) 01/2013 - 07/2002
4	Carcinoma (Carcinomatosis) 09/2012 - 01/2006
3	Small Cell Carcinoma 10/2023 - 04/2015
3	Meningioma (Meningiomas) 10/2016 - 01/2013
3	Stroke (Strokes) 01/2007 - 08/2002
2	Disease Progression 12/2021 - 10/2006
2	Pinealoma (Pineoblastoma) 01/2020 - 09/2012
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2016 - 12/2009
2	Pathologic Complete Response 09/2014 - 12/2009
2	Neuroectodermal Tumors (Neuroectodermal Tumor) 08/2013 - 12/2009
2	Neoplasm Metastasis (Metastasis) 12/2009 - 01/2006
2	Infarction (Infarctions) 01/2007 - 08/2005
2	Brain Ischemia (Cerebral Ischemia) 01/2007 - 08/2005
2	Muscular Dystrophies (Muscular Dystrophy) 09/2006 - 06/2006
2	Ischemia 08/2005 - 07/2002
1	Sarcoma (Soft Tissue Sarcoma) 10/2023
1	Neuroblastoma 10/2022
1	Li-Fraumeni Syndrome 01/2022
1	Central Nervous System Neoplasms 01/2022
1	Chordoma 12/2021
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Turcot syndrome 01/2021
1	Rhabdoid Tumor Predisposition Syndrome 1 01/2021
1	Insulinoma 01/2021
1	Residual Neoplasm 01/2021
1	Paraganglioma (Paragangliomas) 12/2020

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2006
11	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2006
9	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2012
6	Histones (Histone)IBA 01/2019 - 07/2009
4	ChromatinIBA 10/2023 - 03/2016
4	NucleotidesIBA 01/2021 - 01/2018
4	MicroRNAs (MicroRNA)IBA 01/2020 - 11/2010
4	Temozolomide (Temodar)FDA LinkGeneric 01/2017 - 11/2008
4	ParaffinIBA 12/2014 - 10/2009
4	Formaldehyde (Formol)FDA Link 09/2014 - 10/2009
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2011 - 03/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 04/2006
3	Keratins (Keratin)IBA 12/2020 - 10/2008
3	cytidylyl-(3'-5')-cytidine (CpC)IBA 05/2020 - 12/2009
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 05/2020 - 12/2009
3	Messenger RNA (mRNA)IBA 01/2020 - 06/2011
3	hydrogen sulfite (bisulfite)IBA 03/2016 - 01/2009
3	LigandsIBA 01/2016 - 08/2005
3	Tyrosine Kinase InhibitorsIBA 01/2013 - 11/2010
3	Mucin-1 (CA 15-3 Antigen)IBA 12/2009 - 10/2003
3	Erythropoietin FDA Link 11/2008 - 08/2002
2	Adenosine Triphosphate (ATP)IBA 10/2023 - 02/2010
2	AntigensIBA 10/2022 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 06/2011
2	Sucrose (Saccharose)IBA 01/2020 - 11/2016
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019 - 12/2009
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2010
2	AcidsIBA 01/2019 - 03/2016
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2016 - 01/2016
2	AntibodiesIBA 07/2016 - 01/2006
2	Tyrosine (L-Tyrosine)FDA Link 03/2016 - 11/2010
2	Phosphotransferases (Kinase)IBA 01/2016 - 11/2010
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2013 - 01/2013
2	Adenosine Triphosphatases (ATPase)IBA 06/2011 - 02/2010
2	Nonsense Codon (Nonsense Mutation)IBA 06/2011 - 02/2010
2	SynaptophysinIBA 11/2009 - 10/2006
2	Platelet-Derived Growth FactorIBA 10/2009 - 03/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2007 - 08/2005
2	Prealbumin (Transthyretin)IBA 10/2006 - 01/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 09/2006 - 06/2006
1	Chimeric Antigen ReceptorsIBA 10/2022
1	GlypicansIBA 10/2022
1	oncofetal antigensIBA 10/2022
1	CytosineIBA 03/2022
1	NivolumabIBA 12/2021
1	Brachyury protein (Brachyury)IBA 12/2021
1	Decitabine FDA Link 12/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	selinexorIBA 01/2021
1	SMARCB1 ProteinIBA 01/2021
1	Alcian BlueIBA 01/2021
1	DNA Transposable Elements (Element, IS)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Keratin-18 (Keratin 18)IBA 12/2020
1	Oligoclonal BandsIBA 01/2020

Therapy/Procedure

15	Therapeutics 10/2022 - 08/2002
8	Drug Therapy (Chemotherapy) 01/2023 - 11/2008
5	Radiotherapy 01/2024 - 10/2006
4	Ligation 10/2023 - 10/2009
2	Lasers (Laser) 06/2011 - 03/2009